Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
FGFR4 Blocking Peptide (AC1320)
Cat.#: ACPP-1320
Specifications
Despition FGFR4 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1249 TMPRSS2 Blocking Peptide (AC1249) 250 µg inquiry ACPP-1778 Human HSD17B10 Protein (AC1778) 2 µg inquiry ACPP-1017 Recombinant Human FGF19 Protein (AC1017) 50 µg inquiry ACPP-1822 Human CHGA Protein, GST (AC1822) 2 µg inquiry ACPP-1675 Human TOR1A Protein (AC1675) 5 µg inquiry ACPP-1264 SorLA Blocking Peptide (AC1264) 250 µg inquiry ACPP-1618 Human SYT11 Protein (AC1618) 2 µg inquiry ACPP-1002 Recombinant Human CD147 Protein (Fc Tag) (AC1002) 50 µg inquiry ACPP-1144 Synthetic Nanodisc Human GIPR Protein (AC1144) 10 µg inquiry ACPP-1435 Human CHGA Protein, His (AC1435) 2 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket